Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abidol, Oseltamivir, and Lopinavir/Ritonavir in COVID-19 Pneumonia
NCT04255017Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of umifenovir, oseltamivir, lopinavir, ritonavir in coronavirus disease 2019 (COVID-19), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
umifenoviroseltamivirlopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04255017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255017.